Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Rex

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
Antifungal susceptibility testing: technical advances and potential clinical applicationsM A Pfaller, J H Rex, M G Rinaldi
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 25, 1998
Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patientsM D Martins, M Lozano-Chiu, J H Rex
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|July 1, 1997
In vitro growth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistant Candida isolates: influence of assay conditionsP W Nelson, M Lozano-Chiu, J H Rex
The American Journal of Medicine|April 29, 1998
Predictors of adverse outcome in cancer patients with candidemiaE J Anaissie, J H Rex, O Uzun, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1995
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolatesA Wanger, K Mills, P W Nelson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1994
Successful treatment of extensive posttraumatic soft-tissue and renal infections due to Apophysomyces elegansP C Okhuysen, J H Rex, M Kapusta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2001
Risk factors and predictors of outcome in patients with cancer and breakthrough candidemiaO Uzun, S Ascioglu, E J Anaissie, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolatesS Arikan, M Lozano-Chiu, V Paetznick, et al.
Medical Mycology|February 13, 1999
The role of immunoreconstitution in the management of refractory opportunistic fungal infectionsE Roilides, M C Dignani, E J Anaissie, et al.
Journal of Clinical Microbiology|April 16, 1999
Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991M Lozano-Chiu, P W Nelson, V L Paetznick, et al.
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
Antifungal susceptibility testing: technical advances and potential clinical applicationsM A Pfaller, J H Rex, M G Rinaldi
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 25, 1998
Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patientsM D Martins, M Lozano-Chiu, J H Rex
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|July 1, 1997
In vitro growth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistant Candida isolates: influence of assay conditionsP W Nelson, M Lozano-Chiu, J H Rex
The American Journal of Medicine|April 29, 1998
Predictors of adverse outcome in cancer patients with candidemiaE J Anaissie, J H Rex, O Uzun, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1995
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolatesA Wanger, K Mills, P W Nelson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1994
Successful treatment of extensive posttraumatic soft-tissue and renal infections due to Apophysomyces elegansP C Okhuysen, J H Rex, M Kapusta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2001
Risk factors and predictors of outcome in patients with cancer and breakthrough candidemiaO Uzun, S Ascioglu, E J Anaissie, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolatesS Arikan, M Lozano-Chiu, V Paetznick, et al.
Medical Mycology|February 13, 1999
The role of immunoreconstitution in the management of refractory opportunistic fungal infectionsE Roilides, M C Dignani, E J Anaissie, et al.
Journal of Clinical Microbiology|April 16, 1999
Disk diffusion method for determining susceptibilities of Candida spp. to MK-0991M Lozano-Chiu, P W Nelson, V L Paetznick, et al.
Pageof 11